Add like
Add dislike
Add to saved papers

Fabrication and efficient visible light photocatalytic properties of novel zinc indium sulfide (ZnIn2S4) - graphitic carbon nitride (g-C3N4)/bismuth vanadate (BiVO4) nanorod-based ternary nanocomposites with enhanced charge separation via Z-scheme transfer.

Novel ZnIn2S4-g-C3N4/BiVO4 nanorod-based ternary nanocomposite photocatalysts with enhanced visible light absorption were synthesized and systematically characterized to confirm the formation of ZnIn2S4 marigold flowers, the layered structure of the g-C3N4, BiVO4 nanorods, and the formation of binary and ternary nanocomposites. The visible light absorption of BiVO4 was significantly improved after coupling with g-C3N4 and ZnIn2S4, which was confirmed by UV-visible diffuse reflectance spectroscopic analysis. Ternary ZnIn2S4-g-C3N4/BiVO4 nanocomposites exhibited excellent visible light photocatalytic decomposition efficiency (VL-PDE) when used for the degradation of congo red (CR) dye and metronidazole (MTZ) pharmaceutical, as well as excellent stability and reusability. The ternary 5%ZnIn2S4-50%-g-C3N4/BiVO4 nanocomposite showed higher VL-PDE for CR (81.5%) and MTZ (59%) degradation than the binary composites, g-C3N4 and BiVO4. Radical quenching experiments showed that h(+), OH, and O2(-) were the reactive radicals, validating that the Z-scheme charge carrier transfer mechanism was responsible for the enhanced VL-PDE of the ternary ZnIn2S4-g-C3N4/BiVO4 nanocomposites, which was further confirmed by photoluminescence analysis. Furthermore, kinetic studies showed that the degradation followed pseudo-first-order kinetics, and that the ternary photocatalysts could be reused up to three times with good stability. The enhanced visible light absorption, high surface area, high adsorption capacity, Z-scheme charge carrier transfer, and increased lifetime of photo-produced electron-hole pairs were responsible for the increased visible light photocatalytic decomposition efficiency.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app